Search is Powered by Google
Cancer / Oncology News

University Of Texas Medical Branch Might Require Proof Of Residency Before Providing Care To Indigent Patients With Cancer

Main Category: Cancer / Oncology
Also Included In: Public Health
Article Date: 04 Dec 2007 - 8:00 PST

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article


Current Article Ratings:

Patient / Public:2 and a half stars

2.25 (4 votes)

Health Professional:not yet rated

Article Opinions: 0 posts

The Galveston, Texas-based University of Texas Medical Branch is considering requiring patients who need cancer treatment to prove that they are legal residents before it provides care to those who are indigent, the Houston Chronicle reports. The branch's Cancer Patients Acceptance Committee has been considering the policy for months and is expected to make a decision by January 2008. Any changes would take effect immediately.

According to Karen Sexton, vice president and CEO of hospitals and clinics at the branch, the branch's $1.4 billion annual budget included $12 million this year to care for indigent patients with cancer, but the amount fell short. She said, "Everyday, very difficult decisions have to be made because there are too few resources for the demand."

According to the Chronicle, cancer patients turned away at the medical branch likely will see care in Houston or other places. Ronald Walters, associate vice president for medical operations at the University of Texas M.D. Anderson Cancer Center, said, "The Harris County Hospital District, and probably to some degree M.D. Anderson, can't help but be affected by this. It should worry the taxpayers of at least Harris County."

According to the Chronicle, the issue is also "part of a larger debate over immigration, particularly whether illegal immigrants should have access to taxpayer-funded services, including education." Lovell Jones, co-founder of the Intercultural Cancer Center, said, "When you stop providing care for one service, it becomes a slippery slope," adding that Hispanics likely will be affected the most by the policy.

Steven Camarota, director of the Center for Immigration Studies, said, "Every dollar the state of Texas or Harris County and the city of Houston spends on health care for people who aren't supposed to be in the country is a dollar they can't spend on citizens and legal immigrants." According to the center, which supports tighter controls on immigration, undocumented immigrants represent 21% of Texas' uninsured population (Grant, Houston Chronicle, 12/3).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved




Personalized Homepage Weekly Newsletters Daily News Alerts
Opioid Induced Constipation ADHD Anxiety Asthma Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles All 'How To...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
Understanding And Treating Triple-Negative Breast Cancer
07 Jan 2009
Triple-negative breast cancer is a subtype of breast cancer that is clinically negative for expression of estrogen and progesterone receptors (ER/PR) and HER2 protein. It is characterized by its unique molecular profile...


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

View more videos...